IRVINE, CA – Mobix Labs, Inc., a semiconductor company, recently held a Special Meeting of Stockholders where multiple proposals were put to vote, as detailed in a report filed with the SEC today. The meeting, which took place on January 3, 2025, saw the approval of four out of five proposals, with one failing to pass.
The approved proposals include the Equity Grant Proposal, with 28,804,349 votes in favor, and the Equity Incentive Plan Amendment Proposal, which received 32,932,649 affirmative votes. Both initiatives are designed to enhance the company's equity compensation structure.
Additionally, the 2023 Warrant Exercise Proposal and the 2024 Warrant Exercise Proposal were also approved, with 34,066,211 and 35,613,502 votes for, respectively. These proposals allow for the exercise of warrants issued by the company, which could potentially lead to an increase in the number of outstanding shares if the warrant holders choose to exercise their rights to purchase stock.
However, the Certificate of Incorporation Amendment Proposal did not receive the necessary support, with 35,685,144 votes for but not enough to secure approval. The details of the proposed amendment were not disclosed in the press release statement.
The meeting had a quorum with approximately 66.2% of the voting power present, out of the total 35,810,950 shares of Common Stock issued and outstanding as of December 16, 2024.
Mobix Labs, which trades on the Nasdaq Global Market under the ticker MOBX and on the Nasdaq Capital Market for its warrants under MOBXW, is focused on the manufacturing of semiconductors and related devices. The company's stockholders' decisions at the meeting are part of the ordinary course of business in corporate governance, reflecting shareholder influence on company policies and strategic direction.
The information for this news article is based on a press release statement and the company's recent 8-K filing with the SEC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.